Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,069 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ultrafast timing enables reconstruction-free positron emission imaging.
Kwon SI, Ota R, Berg E, Hashimoto F, Nakajima K, Ogawa I, Tamagawa Y, Omura T, Hasegawa T, Cherry SR. Kwon SI, et al. Among authors: nakajima k. Nat Photonics. 2021 Dec;15(12):914-918. doi: 10.1038/s41566-021-00871-2. Epub 2021 Oct 14. Nat Photonics. 2021. PMID: 35663419 Free PMC article.
Neutrino physics for Korean diplomacy.
Carr R, Coleman J, Gratta G, Heeger K, Huber P, Hor Y, Kawasaki T, Kim SB, Kim Y, Learned J, Lindner M, Nakajima K, Seo SH, Suekane F, Vacheret A, Wang W, Zhan L. Carr R, et al. Among authors: nakajima k. Science. 2018 Nov 9;362(6415):649-650. doi: 10.1126/science.aav8136. Science. 2018. PMID: 30409877 No abstract available.
Risk Factors and Prevalence of Sleep Disturbance in Degenerative Cervical Myelopathy.
Nagata K, Nakamoto H, Iwai H, Takeshita Y, Hara N, Azuma S, Higashikawa A, Kawamura N, Oshina M, Hirai S, Masuda K, Sugita S, Ono T, Fukushima M, Nakajima K, Kato S, Taniguchi Y, Matsubayashi Y, Tanaka S, Oshima Y. Nagata K, et al. Among authors: nakajima k. World Neurosurg. 2024 Dec 24:123610. doi: 10.1016/j.wneu.2024.123610. Online ahead of print. World Neurosurg. 2024. PMID: 39725286
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927-5. Online ahead of print. Lancet. 2024. PMID: 39706209
5,069 results